Literature DB >> 4128421

Pyrogenic properties of bleomycin (NSC-125066).

C A Dinarello, S B Ward, S M Wolff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4128421

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  6 in total

Review 1.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

2.  Hyperpigmentation after bleomycin therapy. Ultrastructural study.

Authors:  H Perrot; J P Ortonne
Journal:  Arch Dermatol Res       Date:  1978-05-31       Impact factor: 3.017

3.  Study of histamine release induced by acute administration of antitumor agents in dogs.

Authors:  A Eschalier; J Lavarenne; C Burtin; M Renoux; E Chapuy; M Rodriguez
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Fulminant hyperpyrexia induced by bleomycin.

Authors:  W H Leung; J Y Lau; T K Chan; C R Kumana
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

5.  A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review.

Authors:  F Rosenfelt; J Palmer; I Weinstein; B Rosenbloom
Journal:  Yale J Biol Med       Date:  1982 Sep-Dec

6.  Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma.

Authors:  David A Bond; Emily Dotson; Farrukh T Awan; Robert A Baiocchi; Kristie A Blum; Kami Maddocks
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2018-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.